Lighting a path: Genetic studies pinpoint neurodevelopmental mechanisms in autism and related disorders

Dialogues in Clinical Neuroscience

Volumn 14, Issue 3, 2012, Pages 239-252

  Pescosolido, Matthew F ^a   Yang, Unikora ^a   Sabbagh, Mark ^a   Morrow, Eric M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Autism; Brain development; Regulation of gene expression; Rell signaling; Reuronal cell adhesion molecule; Rynaptic transmission

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FRAGILE X MENTAL RETARDATION PROTEIN; HISTONE METHYLTRANSFERASE; INITIATION FACTOR 4E; NERVE CELL ADHESION MOLECULE; NEUREXIN; NEUROLIGIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; POSTSYNAPTIC RECEPTOR;

ARTICLE; AUTISM; BRAIN DEVELOPMENT; CELL MIGRATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME ABERRATION; COGNITION; CYTOSKELETON; DNA METHYLATION; EPIGENETICS; FRAGILE X SYNDROME; GENE DISRUPTION; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HAPPY PUPPET SYNDROME; HUMAN; INTELLECTUAL IMPAIRMENT; JOUBERT SYNDROME; MACROCEPHALY; MICROCEPHALY; NERVE CELL DIFFERENTIATION; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; PHENOTYPE; POSTSYNAPTIC DENSITY; PROTEIN LOCALIZATION; RNA SPLICING; SIGNAL TRANSDUCTION; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; SYNDROME CHARGE;

AUTISTIC DISORDER; CELL ADHESION MOLECULES, NEURONAL; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION; HUMANS; RNA PRECURSORS; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84875792913     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (119)

1. Ganz ML. The lifetime distribution of the incremental societal costs of autism. Arch Pediatr Adolesc Med. 2007;161:343-349.
2. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012;61:1-19.
3. Anderson DK, Oti RS, Lord C, Welch K. Patterns of growth in adaptive social abilities among children with autism spectrum disorders. J Abnorm Child Psychol. 2009;37:1019-1034.
4. State MW, Levitt P. The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci. 2011;14:1499-1506.
5. Walsh CA, Morrow EM, Rubenstein JL. Autism and brain development. Cell. 2008;135:396-400.
6. Tau GZ, Peterson BS. Normal development of brain circuits. Neuropsychopharmacology. 2010;35:147-168.
7. Mochida GH. Genetics and biology of microcephaly and lissencephaly. Semin Pediatr Neurol. 2009;16:120-126.
8. Dubourg C, Bendavid C, Pasquier L, Henry C, Odent S, David V. Holoprosencephaly. Orphanet J Rare Dis. 2007;2:8.
9. Gleeson JG, Walsh CA. Neuronal migration disorders:from genetic diseases to developmental mechanisms. Trends Neurosci. 2000;23:352-359.
10. Sattar S, Gleeson JG. The ciliopathies in neuronal development:a clinical approach to investigation of Joubert syndrome and Joubert syndromerelated disorders. Dev Med Child Neurol. 2011;53:793-798.
11. Sahin M. Targeted treatment trials for tuberous sclerosis and autism:no longer a dream. Curr Opin Neurobiol. In press.
12. Piven J, Bailey J, Ranson BJ, Arndt S. An MRI study of the corpus callosum in autism. Am J Psychiatry. 1997;154:1051-1056.
13. Booth R, Wallace GL, Happe F. Connectivity and the corpus callosum in autism spectrum conditions:insights from comparison of autism and callosal agenesis. Prog Brain Res. 2011;189:303-317.
14. Huttenlocher PR. Synapse elimination and plasticity in developing human cerebral cortex. Am J Ment Defic. 1984;88:488-496.
15. Huttenlocher PR, de Courten C, Garey LJ, Van der Loos H. Synaptogenesis in human visual cortex - evidence for synapse elimination during normal development. Neurosci Lett. 1982;33:247-252.
16. Krueger DD, Bear MF. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med. 2011;62:411-429.
17. Meguid NA, Fahim C, Sami R, et al. Cognition and lobar morphology in full mutation boys with fragile X syndrome. Brain Cogn. 2012;78:74-84.
18. Miles JH, Hadden LL, Takahashi TN, Hillman RE. Head circumference is an independent clinical finding associated with autism. Am J Med Genet. 2000;95:339-350.
19. Courchesne E, Pierce K, Schumann CM, et al. Mapping early brain development in autism. Neuron. 2007;56:399-413.
20. Butler MG, Dasouki MJ, Zhou XP, et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet. 2005;42:318-321.
21. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009;58:1-20.
22. Belichenko PV, Wright EE, Belichenko NP, et al. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome:evidence for disruption of neuronal networks. J Comp Neurol. 2009;514:240-258.
23. Gecz J, Shoubridge C, Corbett M. The genetic landscape of intellectual disability arising from chromosome X. Trends Genet. 2009;25:308-316.
24. von Bohlen Und Halbach O. Dendritic spine abnormalities in mental retardation. Cell Tissue Res. 2010;342:317-323.
25. Bill BR, Geschwind DH. Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev. 2009;19:271-278.
26. Sanders SJ, Murtha MT, Gupta AR, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature. 2012;485:237-241.
27. Neale BM, Kou Y, Liu L, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012;485:242-245.
28. O'Roak BJ, Vives L, Girirajan S, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012;485:246-250.
29. O'Roak BJ, Deriziotis P, Lee C, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet. 2011;43:585-589.
30. Iossifov I, Ronemus M, Levy D, et al. De novo gene disruptions in children on the autistic spectrum. Neuron. 2012;74:285-299.
31. Martinowich K, Hattori D, Wu H, et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science. 2003;302:890-893.
32. Korzus E, Rosenfeld MG, Mayford M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron. 2004;42:961-972.
33. Guan Z, Giustetto M, Lomvardas S, et al. Integration of long-termmemory- related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure. Cell. 2002;111:483-493.
34. Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature. 2011;474:380-384.
35. Wu JI, Lessard J, Olave IA, et al. Regulation of dendritic development by neuron-specific chromatin remodeling complexes. Neuron. 2007;56:94- 108.
36. Kirilly D, Wong JJ, Lim EK, et al. Intrinsic epigenetic factors cooperate with the steroid hormone ecdysone to govern dendrite pruning in Drosophila. Neuron. 2011;72:86-100.
37. Nan X, Campoy FJ, Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell. 1997;88:471-481.
38. Ben-Shachar S, Chahrour M, Thaller C, Shaw CA, Zoghbi HY. Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet. 2009;18:2431-2442.
39. Skene PJ, Illingworth RS, Webb S, et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell. 2010;37:457-468.
40. Cohen S, Gabel HW, Hemberg M, et al. Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron. 2011;72:72-85.
41. Cukier HN, Rabionet R, Konidari I, et al. Novel variants identified in methyl-CpG-binding domain genes in autistic individuals. Neurogenetics. 2010;11:291-303.
42. Talkowski ME, Mullegama SV, Rosenfeld JA, et al. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet. 2011;89:551-563.
43. Talkowski ME, Rosenfeld JA, Blumenthal I, et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell. 2012;149:525-537.
44. Johansson M, Gillberg C, Rastam M. Autism spectrum conditions in individuals with Mobius sequence, CHARGE syndrome and oculo-auriculovertebral spectrum:diagnostic aspects. Res Dev Disabil. 2010;31:9-24.
45. Kleefstra T, Smidt M, Banning MJ, et al. Disruption of the gene Euchromatin Histone Methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. J Med Genet. 2005;42:299-306.
46. Morrow EM. Genomic copy number variation in disorders of cognitive development. J Am Acad Child Adolesc Psychiatry. 2010;49:1091-1104.
47. Mikhail FM, Lose EJ, Robin NH, et al. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders. Am J Med Genet A. 2011;155A:2386-2396.
48. Martin CL, Duvall JA, Ilkin Y, et al. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:869-876.
49. Shapiro L, Love J, Colman DR. Adhesion molecules in the nervous system: structural insights into function and diversity. Annu Rev Neurosci. 2007;30:451-474.
50. Kelleher RJ, 3rd, Bear MF. The autistic neuron:troubled translation? Cell. 2008;135:401-406.
51. Darnell JC, Van Driesche SJ, Zhang C, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell. 2011;146:247-261.
52. Huber KM, Gallagher SM, Warren ST, Bear MF. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A. 2002;99:7746-7750.
53. Neves-Pereira M, Muller B, Massie D, et al. Deregulation of EIF4E:a novel mechanism for autism. J Med Genet. 2009;46:759-765.
54. Yap CC, Winckler B. Harnessing the power of the endosome to regulate neural development. Neuron. 2012;74:440-451.
55. Schroer RJ, Holden KR, Tarpey PS, et al. Natural history of Christianson syndrome. Am J Med Genet A. 2010;152A:2775-2783.
56. Xinhan L, Matsushita M, Numaza M, Taguchi A, Mitsui K, Kanazawa H. Na+/H+ exchanger isoform 6 (NHE6/SLC9A6) is involved in clathrin-dependent endocytosis of transferrin. Am J Physiol Cell Physiol. 2011;301:C1431- C1444.
57. Orrico A, Galli L, Buoni S, Orsi A, Vonella G, Sorrentino V. Novel PTEN mutations in neurodevelopmental disorders and macrocephaly. Clin Genet. 2009;75:195-198.
58. Castermans D, Wilquet V, Parthoens E, et al. The neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism. J Med Genet. 2003;40:352-356.
59. Giannandrea M, Bianchi V, Mignogna ML, et al. Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. Am J Hum Genet. 2010;86:185-195.
60. Roohi J, Tegay DH, Pomeroy JC, et al. A de novo apparently balanced translocation [46,XY,t(2;9)(p13;p24)] interrupting RAB11FIP5 identifies a potential candidate gene for autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:411-417.
61. Park M, Salgado JM, Ostroff L, et al. Plasticity-induced growth of dendritic spines by exocytic trafficking from recycling endosomes. Neuron. 2006;52:817-830.
62. Bel C, Oguievetskaia K, Pitaval C, Goutebroze L, Faivre-Sarrailh C. Axonal targeting of Caspr2 in hippocampal neurons via selective somatodendritic endocytosis. J Cell Sci. 2009;122:3403-3413.
63. Burbach JP, van der Zwaag B. Contact in the genetics of autism and schizophrenia. Trends Neurosci. 2009;32:69-72.
64. Girirajan S, Brkanac Z, Coe BP, et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet. 2011;7:e1002334.
65. Chapleau CA, Larimore JL, Theibert A, Pozzo-Miller L. Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism. J Neurodev Disord. 2009;1:185-196.
66. Glessner JT, Wang K, Cai G, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009;459:569-573.
67. Joazeiro CA, Hunter T. Biochemistry. Ubiquitination - more than two to tango. Science. 2000;289:2061-2062.
68. Murphey RK, Godenschwege TA. New roles for ubiquitin in the assembly and function of neuronal circuits. Neuron. 2002;36:5-8.
69. Smith SE, Zhou YD, Zhang G, Jin Z, Stoppel DC, Anderson MP. Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci Transl Med. 2011;3:103ra97.
70. Mabb AM, Judson MC, Zylka MJ, Philpot BD. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci. 2011;34:293-303.
71. Nascimento RM, Otto PA, de Brouwer AP, Vianna-Morgante AM. UBE2A, which encodes a ubiquitin-conjugating enzyme, is mutated in a novel Xlinked mental retardation syndrome. Am J Hum Genet. 2006;79:549-555.
72. Fatemi SH. Reelin glycoprotein in autism and schizophrenia. Int Rev Neurobiol. 2005;71:179-187.
73. Arnaud L, Ballif BA, Cooper JA. Regulation of protein tyrosine kinase signaling by substrate degradation during brain development. Mol Cell Biol. 2003;23:9293-9302.
74. Patrick GN. Synapse formation and plasticity:recent insights from the perspective of the ubiquitin proteasome system. Curr Opin Neurobiol. 2006;16:90-94.
75. Campbell DS, Holt CE. Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron. 2001;32:1013-1026.
76. Keleman K, Rajagopalan S, Cleppien D, et al. Comm sorts robo to control axon guidance at the Drosophila midline. Cell. 2002;110:415-427.
77. Abrahams BS, Geschwind DH. Connecting genes to brain in the autism spectrum disorders. Arch Neurol. 2010;67:395-399.
78. Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol. 2009;19:231- 234.
79. Grantyn R, Henneberger C, Juttner R, Meier JC, Kirischuk S. Functional hallmarks of GABAergic synapse maturation and the diverse roles of neurotrophins. Front Cell Neurosci. 2011;5:13.
80. Fassio A, Patry L, Congia S, et al. SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum Mol Genet. 2011;20:2297-307.
81. Kao HT, Porton B, Czernik AJ, et al. A third member of the synapsin gene family. Proc Natl Acad Sci U S A. 1998;95:4667-4672.
82. Feng J, Chi P, Blanpied TA, et al. Regulation of neurotransmitter release by synapsin III. J Neurosci. 2002;22:4372-4380.
83. Augustin I, Rosenmund C, Sudhof TC, Brose N. Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature. 1999;400:457- 461.
84. Volders K, Nuytens K, Creemers JW. The autism candidate gene Neurobeachin encodes a scaffolding protein implicated in membrane trafficking and signaling. Curr Mol Med. 2011;11:204-217.
85. Richter JD, Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature. 2005;433:477-480.
86. Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci. 2005;8:1727-1734.
87. Choi YJ, Di Nardo A, Kramvis I, et al. Tuberous sclerosis complex proteins control axon formation. Genes Dev. 2008;22:2485-2495.
88. Bateup HS, Takasaki KT, Saulnier JL, Denefrio CL, Sabatini BL. Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function. J Neurosci. 2011;31:8862-889.
89. Fu C, Cawthon B, Clinkscales W, Bruce A, Winzenburger P, Ess KC. GABAergic interneuron development and function is modulated by the tsc1 gene. Cereb Cortex. 2012;22:2111-2119.
90. Kelleher RJ, Geigenmuller U, Hovhannisyan H, et al. High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism. PLoS One. 2012;7:e35003.
91. Rodriguez-Escudero I, Oliver MD, Andres-Pons A, Molina M, Cid VJ, Pulido R. A comprehensive functional analysis of PTEN mutations:implications in tumor- and autism-related syndromes. Hum Mol Genet. 2011;20:4132-4142.
92. Amiri A, Cho W, Zhou J, et al. Pten deletion in adult hippocampal neural stem/progenitor cells causes cellular abnormalities and alters neurogenesis. J Neurosci. 2012;32:5880-5890.
93. Kwon CH, Luikart BW, Powell CM, et al. Pten regulates neuronal arborization and social interaction in mice. Neuron. 2006;50:377-388.
94. Kumar RA, KaraMohamed S, Sudi J, et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet. 2008;17:628-638.
95. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med. 2008;358:667- 675.
96. Zou H, Yu Y, Sheikh AM, et al. Association of upregulated Ras/Raf/ERK1/2 signaling with autism. Genes Brain Behav. 2011;10:615-624.
97. Yang K, Cao F, Sheikh AM, et al. Up-regulation of Ras/Raf/ERK1/2 signaling impairs cultured neuronal cell migration, neurogenesis, synapse formation, and dendritic spine development. Brain Struct Funct. In press.
98. Martinez de Lagran M, Benavides-Piccione R, Ballesteros-Yanez I, et al. Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons. Cereb Cortex. In press.
99. Berkel S, Marshall CR, Weiss B, et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet. 2010;42:489-491.
100. Durand CM, Betancur C, Boeckers TM, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet. 2007;39:25-27.
101. Sato D, Lionel AC, Leblond CS, et al. SHANK1 deletions in males with autism spectrum disorder. Am J Hum Genet. 2012;90:879-887.
102. Sykes NH, Toma C, Wilson N, et al. Copy number variation and association analysis of SHANK3 as a candidate gene for autism in the IMGSAC collection. Eur J Hum Genet. 2009;17:1347-1353.
103. Bonaglia MC, Giorda R, Mani E, et al. Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome. J Med Genet. 2006;43:822-828.
104. Grabrucker AM, Knight MJ, Proepper C, et al. Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation. EMBO J. 2011;30:569-581.
105. Choi YB, Li HL, Kassabov SR, et al. Neurexin-neuroligin transsynaptic interaction mediates learning-related synaptic remodeling and long-term facilitation in aplysia. Neuron. 2011;70:468-481.
106. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008;82:477-488.
107. Alarcon M, Abrahams BS, Stone JL, et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet. 2008;82:150-159.
108. Jamain S, Quach H, Betancur C, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet. 2003;34:27-29.
109. Sudhof TC, Rothman JE. Membrane fusion:grappling with SNARE and SM proteins. Science. 2009;323:474-477.
110. Varoqueaux F, Aramuni G, Rawson RL, et al. Neuroligins determine synapse maturation and function. Neuron. 2006;51:741-754.
111. Lawson-Yuen A, Saldivar JS, Sommer S, Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet. 2008;16:614-618.
112. Arking DE, Cutler DJ, Brune CW, et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet. 2008;82:160-164.
113. Kattenstroth G, Tantalaki E, Sudhof TC, Gottmann K, Missler M. Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. Proc Natl Acad Sci U S A. 2004;101:2607-2612.
114. Jiang Y, Langley B, Lubin FD, et al. Epigenetics in the nervous system. J Neurosci. 2008;28:11753-11759.
115. Shulha HP, Cheung I, Whittle C, et al. Epigenetic signatures of autism:trimethylated H3K4 landscapes in prefrontal neurons. Arch Gen Psychiatry. 2012;69:314-324.
116. Anderson DK, Lord C, Risi S, et al. Patterns of growth in verbal abilities among children with autism spectrum disorder. J Consult Clin Psychol. 2007;75:594-604.
117. Bystron I, Blakemore C, Rakic P. Development of the human cerebral cortex: Boulder Committee revisited. Nat Rev Neurosci. 2008;9:110-122.
118. Stiles J, Jernigan TL. The basics of brain development. Neuropsychol Rev. 2010;20:327-348.
119. Volpe JJ. Neurology of the Newborn. 5th ed. Philadelphia, PA: Saunders; 2008.